超快速胚胎复温方案的围产期结局:单中心1020例活产分析
共分析3657个移植周期中的4061次囊胚复温事件,超快速组2761次、传统组1300次。两种方法胚胎存活率均为99%,活产率相当(37%对35.4%),围产期健康结局无显著差异。
要点
- 超快速复温与传统复温的胚胎存活率均为99%。
- 超快速组活产率37%,传统组35.4%,两组相当。
- 围产期结局包括胎龄、出生体重和双胎率无显著差异。
核心结论
- 超快速复温方案提供与传统复温相当的胚胎学和临床结局,且对围产期健康无明显不良影响。
研究设计与样本
- 共分析3657个胚胎移植周期中的4061次囊胚复温事件,超快速组2761次,传统组1300次。
主要发现
- 两种复温方法的胚胎存活率均为99%。
- 超快速组活产率为37%,传统组为35.4%,两组可比。
- 围产期健康结局包括胎龄、新生儿出生体重和双胎率未见显著差异。
临床怎么用
- 超快速复温方案可作为辅助生殖中的常规方法,维持最佳患者结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: Does the use of embryo warming with an ultrafast protocol influence clinical and perinatal health outcomes when compared with conventional warming protocols? DESIGN: A retrospective cohort study was conducted at a single IVF centre evaluating frozen embryo transfer cycles performed between November 2023 and December 2024. Traditionally vitrified embryos were subsequently warmed using either traditional or ultrafast protocols. Live birth rate and perinatal outcomes including gestational age, neonatal birthweight and twin rates were calculated. RESULTS: A total of 4061 blastocyst warming events in 3657 embryo transfer cycles were analysed, of which 2761 involved warming using an ultrafast protocol and 1300 warming using a traditional protocol. Embryo survival was 99% following both methods. Live birth rates were comparable (37% versus 35.4%). No significant differences were observed in perinatal health outcomes. CONCLUSIONS: Warming with an ultrafast protocol provides excellent embryological and clinical outcomes equivalent to those achieved with traditional warming, without evident adverse effects on perinatal health outcomes. These findings support the efficiency of the ultrafast protocol as a routine approach in assisted reproduction and its potential to maintain optimal patient outcomes.
引用
- Linara-Demakakou E, Shah T, Al-Hashimi B, et al. Embryo warming using an ultrafast protocol: perinatal outcomes from 1020 births from a single UK IVF centre. Reprod Biomed Online. 2026. PMID: 42025140. doi:10.1016/j.rbmo.2026.105696
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。